Oncology Medical News about Esophageal Neoplasms Lipoproteins, LDL

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. Recommendations on the use of 18F-FDG PET in oncology

3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials

4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer

5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Association of serum levels of lipid and its novel constituents with the different stages of esophageal carcinoma
Lipids in Health and Disease, 10/30/09

Diao Y et al. – The present study shows that the decreased oxidized low–density lipoprotein (oxLDL) and autoantibodies against oxLDL (oxLDL–ab) and the elevated oxLDL–lgM serum levels may relate to the development and progression of esophageal squamous cell carcinoma (ESSC).

<< Previous
Can permeability measurements add to blood volume measurements in...

Next >>
Mammographic Screening and Risk Factors for Breast Cancer

Coronary artery endothelial dysfunction is positively correlated with low density lipoprotein and inversely correlated with high density lipoprotein subclass particles measured by nuclear magnetic resonance spectroscopy
Atherosclerosis, 11/12/09 Relevance Score: 69%

Management of Hypercholesterolemia
Geriatrics & Aging, 11/12/09 Relevance Score: 68%

Effectiveness of rosuvastatin in reducing LDL-C and target LDL-C goal attainment in real-world clinical practice
Current Medical Research and Opinion, 10/22/09 Relevance Score: 68%

Metabolism of Very-Low-Density Lipoprotein and Low-Density Lipoprotein Containing Apolipoprotein C-III and Not Other Small Apolipoproteins
Arteriosclerosis, Thrombosis, and Vascular Biology, 11/17/09 Relevance Score: 67%

Critical appraisal of the role of pitavastatin in treating dyslipidemias and achieving lipid goals
Vascular Health and Risk Management, 11/03/09 Relevance Score: 67%